These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25697685)

  • 1. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.
    Niu G; Pang Z; Guan C; Qi J; Li D
    Virus Res; 2015 Apr; 201():73-8. PubMed ID: 25697685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
    Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
    Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.
    Hapugoda MD; Batra G; Abeyewickreme W; Swaminathan S; Khanna N
    Clin Vaccine Immunol; 2007 Nov; 14(11):1505-14. PubMed ID: 17898184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, refolding and bio-structural analysis of a tetravalent recombinant dengue envelope domain III protein for serological diagnosis.
    Combe M; Lacoux X; Martinez J; Méjan O; Luciani F; Daniel S
    Protein Expr Purif; 2017 May; 133():57-65. PubMed ID: 28274805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera.
    Batra G; Nemani SK; Tyagi P; Swaminathan S; Khanna N
    BMC Infect Dis; 2011 Mar; 11():64. PubMed ID: 21401963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
    Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
    Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant multiepitope protein for early detection of dengue infections.
    Anandarao R; Swaminathan S; Fernando S; Jana AM; Khanna N
    Clin Vaccine Immunol; 2006 Jan; 13(1):59-67. PubMed ID: 16426001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and heterologous expression of dengue virus envelope protein (E) peptides and their use for serological diagnosis.
    Honda ER; Zanchi F; Rios K; Lira E; DeusileneVieira ; da Silva LH; De Paula SO
    J Virol Methods; 2012 Dec; 186(1-2):55-61. PubMed ID: 22981980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and preliminary application of dengue virus envelope domain III IgG antibody capture enzyme-linked immuno-absorbent assay].
    Hu DM; Cai JP; Wang DH; DI B; Qiu LW; Wang YD; Chen Y; Ding XX; Che XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):363-6. PubMed ID: 23928645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus.
    Khan M; Dhanwani R; Kumar JS; Rao PV; Parida M
    J Med Virol; 2014 Jul; 86(7):1169-75. PubMed ID: 24105844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections.
    Rockstroh A; Barzon L; Pacenti M; Palù G; Niedrig M; Ulbert S
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004218. PubMed ID: 26565964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
    Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
    J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.
    Cuzzubbo AJ; Endy TP; Nisalak A; Kalayanarooj S; Vaughn DW; Ogata SA; Clements DE; Devine PL
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1150-5. PubMed ID: 11687456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of E and NS1 antigens capture ELISA to detect dengue viral antigens from mosquitoes.
    Chao DY; Liu YJ; Shen WF; Tu WC; Galula JU; Wu HC
    J Vector Borne Dis; 2015 Jun; 52(2):134-41. PubMed ID: 26119545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.
    dos Santos FB; Miagostovich MP; Nogueira RM; Schatzmayr HG; Riley LW; Harris E
    Am J Trop Med Hyg; 2004 Aug; 71(2):144-52. PubMed ID: 15306702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.